Insulin-like Growth Factor 1 System in Early-Stage Cervical Cancer
Author Information
Author(s): Huang Y-F, Shen M-R, Hsu K-F, Cheng Y-M, Chou C-Y
Primary Institution: National Cheng Kung University, Tainan, Taiwan
Hypothesis
This study aimed to identify the expression and the correlation of insulin-like growth factor-1 (IGF-1) system and their prognostic impacts in cervical cancer.
Conclusion
High-grade expression of IGF-1R is an independent predictor of death and recurrence in early-stage cervical cancer patients.
Supporting Evidence
- High-grade expression of IGF-1R was associated with significantly lower 5-year recurrence-free and overall survival rates.
- Preoperative serum total IGF-1 or IGFBP-3 levels did not predict cancer death and recurrence.
- Combination of high-grade IGF-1R expression and elevated preoperative SCC Ag level could identify patients at higher death risk.
Takeaway
This study found that a specific protein related to insulin, called IGF-1R, can help doctors predict how likely it is for patients with early-stage cervical cancer to survive or have their cancer come back.
Methodology
The study analyzed serum levels of total IGF-1 and IGFBP-3 and the expression of IGF-1R in cancerous tissue using enzyme-linked immunosorbent assay and immunofluorescent stains.
Potential Biases
Potential biases may arise from the selection of patients and the retrospective nature of the study.
Limitations
The study is retrospective and may not account for all variables affecting patient outcomes.
Participant Demographics
Patients were women with early-stage cervical cancer who underwent surgery.
Statistical Information
P-Value
P=0.003 and P=0.01
Confidence Interval
95% CI: 1.20–14.55
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website